Both in Pharmaceuticals
Biomea Fusion vs InMed Pharmaceuticals
Over the past year BMEA returned −51.4% and INM returned +405.8%; their daily moves had a correlation of 0.02.
BMEA −51.4% INM +405.8%Growth of $1, one year, split-adjusted
| Metric | BMEA | INM |
|---|---|---|
| Price | $0.6119 | $8.75 |
| Market cap | $44.4M | $48.1M |
| Today | −1.91% | +420.83% |
| 1 month | −51.0% | +557.9% |
| 6 months | −61.8% | +1104.6% |
| Year to date | −50.7% | +725.5% |
| 1 year | −53.6% | +373.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 24.8× |
| Net cash | $34.8M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 122.0% | 338.3% |
| Short % of float | 24.1% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).